- Incidence, predictive factors, and prognosis for winged scapula in breast cancer patients after axillary dissection.
Nevola Teixeira LF, Lohsiriwat V, Schorr MC, Luini A, Galimberti V, Rietjens M, Garusi C, Gandini S, Sarian LO, Sandrin F, Simoncini MC, Veronesi P.
Support Care Cancer. 2014 Feb 4. [Epub ahead of print]
PMID: 2449292 - Outcomes of patients with breast cancer who present with ipsilateral supraclavicular or internal mammary lymph node metastases.
Dellapasqua S, Bagnardi V, Balduzzi A, Iorfida M, Rotmensz N, Santillo B, Viale G, Ghisini R, Veronesi P, Luini A, Morra A, Goldhirsch A, Colleoni M.
Clin Breast Cancer. 2014 Feb;14(1):53-60. doi: 10.1016/j.clbc.2013.09.008. Epub 2013 Sep 27.
PMID: 24183613 - Pathological features and survival outcomes of very young patients with early breast cancer: how much is “very young”?
Cancello G, Maisonneuve P, Mazza M, Montagna E, Rotmensz N, Viale G, Pruneri G, Veronesi P,Luini A, Gentilini O, Goldhirsch A, Colleoni M.
Breast. 2013 Dec;22(6):1046-51. doi: 10.1016/j.breast.2013.08.006. Epub 2013 Sep 30.
PMID: 24091127 - Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.
Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, Luini A, Veronesi P, Galimberti V, Zurrida S, Leonardi MC, Lazzari R, Cattani F, Gentilini O, Intra M, Caldarella P, Ballardini B.
Lancet Oncol. 2013 Dec;14(13):1269-77. doi: 10.1016/S1470-2045(13)70497-2. Epub 2013 Nov 11.
PMID: 24225155 - Breast phyllodes tumor: a review of literature and a single center retrospective series analysis.
Spitaleri G, Toesca A, Botteri E, Bottiglieri L, Rotmensz N, Boselli S, Sangalli C, Catania C, Toffalorio F, Noberasco C, Delmonte A, Luini A, Veronesi P, Colleoni M, Viale G, Zurrida S, Goldhirsch A, Veronesi U, De Pas T.
Crit Rev Oncol Hematol. 2013 Nov;88(2):427-36. doi: 10.1016/j.critrevonc.2013.06.005. Epub 2013 Jul 17.
PMID: 23871531 - Survival Outcomes in Breast Cancer Patients With Low Estrogen/Progesterone Receptor Expression.
Balduzzi A, Bagnardi V, Rotmensz N, Dellapasqua S, Montagna E, Cardillo A, Viale G, Veronesi P, Intra M, Luini A, Pruneri G, Mastropasqua G, Goldhirsch A, Colleoni M.
Clin Breast Cancer. 2013 Oct 26. pii: S1526-8209(13)00256-5. doi: 10.1016/j.clbc.2013.10.019. [Epub ahead of print]
PMID: 24325948 - The clinical relevance of micropapillary carcinoma of the breast: a case-control study.
Vingiani A, Maisonneuve P, Dell’orto P, Farante G, Rotmensz N, Lissidini G, Del Castillo A, Renne G,Luini A, Colleoni M, Viale G, Pruneri G.
Histopathology. 2013 Aug;63(2):217-24. doi: 10.1111/his.12147. Epub 2013 Jun 13.
PMID: 23763700 - A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer.
Serrano D, Lazzeroni M, Gandini S, Macis D, Johansson H, Gjerde J, Lien E, Feroce I, Pruneri G, Sandri MT, Bassi F, Brenelli F, Luini A, Cazzaniga M, Varricchio C, Guerrieri-Gonzaga A, Decensi A, Bonanni B.
Breast Cancer Res. 2013 Jun 20;15(3):R47. [Epub ahead of print]
PMID: 23786776 - Immunohistochemically defined subtypes and outcome of apocrine breast cancer.
Dellapasqua S, Maisonneuve P, Viale G, Pruneri G, Mazzarol G, Ghisini R, Mazza M, Iorfida M, Rotmensz N, Veronesi P, Luini A, Goldhirsch A, Colleoni M.
Clin Breast Cancer. 2013 Apr;13(2):95-102. doi: 10.1016/j.clbc.2012.11.004. Epub 2012 Dec 14.
PMID: 23245877 - Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U; International Breast Cancer Study Group Trial 23-01 investigators.
Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11. Erratum in: Lancet Oncol. 2013 Jun;14(7):e254.
PMID: 23491275 - Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse.
Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, Montagna E, Iorfida M, Mazza M, Balduzzi A, Veronesi P, Luini A, Intra M, Goldhirsch A, Colleoni M.
Ann Oncol. 2013 Mar;24(3):661-8. doi: 10.1093/annonc/mds430. Epub 2012 Sep 28.
PMID: 23022996 - Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.
Montagna E, Maisonneuve P, Rotmensz N, Cancello G, Iorfida M, Balduzzi A, Galimberti V, Veronesi P, Luini A, Pruneri G, Bottiglieri L, Mastropasqua MG, Goldhirsch A, Viale G, Colleoni M.
Clin Breast Cancer. 2013 Feb;13(1):31-9. doi: 10.1016/j.clbc.2012.09.002. Epub 2012 Oct 24.
PMID: 23098574 - Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection.
Leonardi MC, Maisonneuve P, Mastropasqua MG, Morra A, Lazzari R, Dell’Acqua V, Ferrari A, Rotmensz N, Sangalli C, Luini A, Veronesi U, Orecchia R.
Radiother Oncol. 2013 Jan;106(1):21-7. doi: 10.1016/j.radonc.2012.10.018. Epub 2012 Dec 3.
PMID: 23218711